In RCC, RCC-derived CXCL5 promotes fibrosis by activating the JAK/STAT3 pathway, facilitating the transformation of normal fibroblasts into CAFs (Liu Y. et al., 2023). This evidence concerns the gene STAT3 and renal cell carcinoma.